These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Percutaneous closure of patent foramen ovale vs. medical treatment for patients with history of cryptogenic stroke: A systematic review and meta-analysis of randomized controlled trials. Palaiodimos L, Kokkinidis DG, Faillace RT, Foley TR, Dangas GD, Price MJ, Mastoris I. Cardiovasc Revasc Med; 2018; 19(7 Pt B):852-858. PubMed ID: 29576519 [Abstract] [Full Text] [Related]
25. Patent foramen ovale closure versus medical therapy for cryptogenic stroke: An updated meta-analysis. Xu HB, Zhang H, Qin Y, Xue F, Xiong G, Yang L, Bai H, Wu J. J Neurol Sci; 2018 Jul 15; 390():139-149. PubMed ID: 29801875 [Abstract] [Full Text] [Related]
26. Updated meta-analysis of closure of patent foramen ovale versus medical therapy after cryptogenic stroke. Nasir UB, Qureshi WT, Jogu H, Wolfe E, Dutta A, Majeed CN, Tan WA. Cardiovasc Revasc Med; 2019 Mar 15; 20(3):187-193. PubMed ID: 30905408 [Abstract] [Full Text] [Related]
27. Closure of patent foramen ovale or medical therapy alone for secondary prevention of cryptogenic cerebrovascular events. Fortuni F, Crimi G, Leonardi S, Angelini F, Raisaro A, Lanzarini LF, Oltrona Visconti L, Ferrario M, De Ferrari GM. J Cardiovasc Med (Hagerstown); 2018 Jul 15; 19(7):373-381. PubMed ID: 29708911 [Abstract] [Full Text] [Related]
30. Patent foramen ovale closure or medical therapy for cryptogenic ischemic stroke: an updated meta-analysis of randomized controlled trials. Schulze V, Lin Y, Karathanos A, Brockmeyer M, Zeus T, Polzin A, Perings S, Kelm M, Wolff G. Clin Res Cardiol; 2018 Sep 15; 107(9):745-755. PubMed ID: 29500568 [Abstract] [Full Text] [Related]
31. Long-term experience and outcomes with transcatheter closure of patent foramen ovale. Inglessis I, Elmariah S, Rengifo-Moreno PA, Margey R, O'Callaghan C, Cruz-Gonzalez I, Baron S, Mehrotra P, Tan TC, Hung J, Demirjian ZN, Buonanno FS, Ning M, Silverman SB, Cubeddu RJ, Pomerantsev E, Schainfeld RM, Dec GW, Palacios IF. JACC Cardiovasc Interv; 2013 Nov 15; 6(11):1176-83. PubMed ID: 24262618 [Abstract] [Full Text] [Related]
32. PFO closure vs. medical therapy in cryptogenic stroke or transient ischemic attack: a systematic review and meta-analysis. Ntaios G, Papavasileiou V, Makaritsis K, Michel P. Int J Cardiol; 2013 Oct 30; 169(2):101-5. PubMed ID: 24041984 [Abstract] [Full Text] [Related]
33. Percutaneous closure of patent foramen ovale for cryptogenic stroke: a meta-analysis of randomized controlled trials. Kwong JS, Lam YY, Yu CM. Int J Cardiol; 2013 Oct 09; 168(4):4132-8. PubMed ID: 23890879 [Abstract] [Full Text] [Related]
36. A meta-analysis of transcatheter closure of patent foramen ovale versus medical therapy for prevention of recurrent thromboembolic events in patients with cryptogenic cerebrovascular events. Pineda AM, Nascimento FO, Yang SC, Kirtane AJ, Sommer RJ, Beohar N. Catheter Cardiovasc Interv; 2013 Nov 15; 82(6):968-75. PubMed ID: 23832613 [Abstract] [Full Text] [Related]
38. Recurrent events after percutaneous closure of patent foramen ovale. Wallenborn J, Bertog SC, Franke J, Steinberg DH, Majunke N, Wilson N, Wunderlich N, Sievert H. Catheter Cardiovasc Interv; 2013 Oct 01; 82(4):541-6. PubMed ID: 22707325 [Abstract] [Full Text] [Related]